Directory

>

Srikumar Sahasranaman

avatar

Srikumar Sahasranaman

SVP, Quantitative Clinical Pharmacology | Prelude Therapeutics

Menlo Park, California, United States

View contact details (it's free)

Srikumar Sahasranaman

Summary

Srikumar Sahasranaman is an accomplished pharmaceutical executive with extensive experience in quantitative clinical pharmacology. Currently serving as SVP at Prelude Therapeutics, he has a rich background in drug development, focusing on biomarkers, pharmacodynamics, and translational medicine. With a Ph.D. in Pharmaceutical Sciences from the University of Florida, he has held leadership roles at notable companies such as Beigene and Genentech. His expertise spans across clinical development and pharmacokinetics, making him a key player in the pharmaceutical industry. Srikumar's contributions to pediatric pharmacokinetics during his internship at the FDA highlight his commitment to advancing healthcare. He has also served on the Board of Directors for the IQ Consortium, indicating his influence in shaping industry standards. His career reflects a blend of scientific rigor and strategic leadership, positioning him as a thought leader in clinical pharmacology.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Consulting Experience

Srikumar Sahasranaman

Work Experience

company logo

SVP, Quantitative Clinical Pharmacology at

Prelude Therapeutics

April 2023 - Present

company logo

Member, Board Of Directors at

IQ Consortium

January 2021 - March 2023

company logo

Vice President, Clinical Pharmacology at

BeiGene

January 2017 - March 2023

company logo

Group Leader/Senior Scientist, Clinical Pharmacology at

Genentech Foundation

May 2010 - December 2016

company logo

Expert Pharmacokineticist at

Novartis

September 2006 - May 2010

company logo

Senior Research Investigator at

Sanofi

August 2004 - September 2006

company logo

Intern at

FDA

June 2003 - August 2003

Logos provided by Logo.dev

Srikumar Sahasranaman

Education

University of Florida, Ph.D.

January 2000 - January 2004

National University of Singapore, M.S.

January 1998 - January 2000

Birla Institute of Technology and Science, Pilani , B.Pharm (Hons.)

January 1993 - January 1997

Frequently Asked Questions about Srikumar Sahasranaman

What is Srikumar Sahasranaman email address?

Srikumar Sahasranaman's primary email address is *********************@beigene.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Srikumar Sahasranaman work for?

Srikumar Sahasranaman is a SVP, Quantitative Clinical Pharmacology at Prelude Therapeutics, a company specializing in Commercial physical research.

Where Srikumar Sahasranaman graduated from?

Srikumar Sahasranaman holds a degree in Pharmaceutical Sciences from University of Florida.

How can I directly contact Srikumar Sahasranaman?

To contact Srikumar Sahasranaman directly, you can use the email address *********************@beigene.com. Complete contact information is available upon registration with Muraena.

Is Srikumar Sahasranaman an immigrant?

Yes, Srikumar Sahasranaman is an immigrant and currently based in United States

Who is Srikumar Sahasranaman?

Srikumar Sahasranaman is an accomplished pharmaceutical executive with extensive experience in quantitative clinical pharmacology. Currently serving as SVP at Prelude Therapeutics, he has a rich background in drug development, focusing on biomarkers, pharmacodynamics, and translational medicine. With a Ph.D. in Pharmaceutical Sciences from the University of Florida, he has held leadership roles at notable companies such as Beigene and Genentech. His expertise spans across clinical development and pharmacokinetics, making him a key player in the pharmaceutical industry. Srikumar's contributions to pediatric pharmacokinetics during his internship at the FDA highlight his commitment to advancing healthcare. He has also served on the Board of Directors for the IQ Consortium, indicating his influence in shaping industry standards. His career reflects a blend of scientific rigor and strategic leadership, positioning him as a thought leader in clinical pharmacology.

Srikumar`s contact details

mail

*********************@beigene.com

*************@preludetx.com

Colleagues

avatar
Peggy Scherle

Chief Scientific Officer

Andrew Combs

Chief Chemistry Officer

avatar
Tim Mueller

Vice President EHS, Lab Operations, & Facilities

avatar
Kris Vaddi

Chief Executive Officer and Founder

avatar
Michele Porreca

Chief People Officer

avatar
Murty Mangena

Executive Director, Technical Operations

avatar
Lisa Carson

Vice President, Head of Finance & Controller

avatar
Sandy Geeganage

Vice President - Drug Discovery

Sang Hyun Lee

Vice President of Biology

avatar
Naveen Babbar

Senior Vice President, Translation Medicine

View Contact details (it's free)
Request Profile Removal